Related references
Note: Only part of the references are listed.Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?
Tiziano Barbui et al.
BLOOD (2009)
Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference
Giovanni Barosi et al.
BLOOD (2009)
Reticulin Accumulation in Essential Thrombocythemia: Prognostic Significance and Relationship to Therapy
Peter J. Campbell et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Increase in leukocyte count over time predicts thrombosis in patients with low-risk essential thrombocythemia
F. Passamonti et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera
Marina Marchetti et al.
BLOOD (2008)
Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera
Raffaele Landolfi et al.
BLOOD (2007)
Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status
Alessandra Carobbio et al.
BLOOD (2007)
Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status:: a prospective study
PJ Campbell et al.
LANCET (2005)
Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia
CN Harrison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera
A Falanga et al.
EXPERIMENTAL HEMATOLOGY (2005)
Share Paper
